Načítá se...
Cancer neoantigens as potential targets for immunotherapy
Immune checkpoint inhibitors (ICIs) targeting the cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) and programed cell death protein 1 (PD-1) or its ligand PD-L1 have increased the survival and cure rates for patients with many cancer types in various disease settings. However, only 10–40% of can...
Uloženo v:
| Vydáno v: | Clin Exp Metastasis |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Netherlands
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8097110/ https://ncbi.nlm.nih.gov/pubmed/33950415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10585-021-10091-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|